Fenofibrate, a peroxisome proliferator-activated receptor a agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice

Kazunari Kondo, Tadao Sugioka, Kosuke Tsukada, Michiyoshi Aizawa, Masayuki Takizawa, Kenji Shimizu, Masaya Morimoto, Makoto Suematsu, Nobuhito Goda

Research output: Chapter in Book/Report/Conference proceedingConference contribution

23 Citations (Scopus)

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a common disease of chronic liver diseases. Peroxisome proliferator-activated receptor a (PPARa) has been implicated to play important roles in the development of the disease. Beyond its effects on lipidmetabolisms, PPARa activation in the vascular system has emerged as an attractive therapeutic potential for NAFLD, although its actions in the microcirculatory system are not fully understood. In this study, we investigated the effects of fenofibrate, a PPARa synthetic agonist, on hepatic microcirculation in a high-fat diet (HFD)-induced fatty liver in mice. In vivo imaging analysis revealed the adverse effects of HFDon hepatic vasculature with narrowing of hepatic sinusoids and hepatic microcirculatory perfusion. Oxygen tension was significantly decreased in portal venules, while NADH autofluorescence in hepatocytes was greatly elevated. Fenofibrate treatment remarkably improved microvascular patency, tissue oxygenation and redox states in the affected liver. These results suggest beneficial roles of PPARa activated by fenofibrate on the regulation of both lipid metabolisms and microvascular environments of oxygen metabolism in HFD-induced fatty liver.

Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
Pages77-82
Number of pages6
Volume662
DOIs
Publication statusPublished - 2010
Externally publishedYes

Publication series

NameAdvances in Experimental Medicine and Biology
Volume662
ISSN (Print)00652598

Fingerprint

Fenofibrate
Peroxisome Proliferator-Activated Receptors
High Fat Diet
Fatty Liver
Nutrition
Liver
Fats
Availability
Oxygen
Venules
Microcirculation
Oxygenation
Lipid Metabolism
NAD
Oxidation-Reduction
Blood Vessels
Liver Diseases
Hepatocytes
Metabolism
Chronic Disease

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Kondo, K., Sugioka, T., Tsukada, K., Aizawa, M., Takizawa, M., Shimizu, K., ... Goda, N. (2010). Fenofibrate, a peroxisome proliferator-activated receptor a agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice. In Advances in Experimental Medicine and Biology (Vol. 662, pp. 77-82). (Advances in Experimental Medicine and Biology; Vol. 662). https://doi.org/10.1007/978-1-4419-1241-1_10

Fenofibrate, a peroxisome proliferator-activated receptor a agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice. / Kondo, Kazunari; Sugioka, Tadao; Tsukada, Kosuke; Aizawa, Michiyoshi; Takizawa, Masayuki; Shimizu, Kenji; Morimoto, Masaya; Suematsu, Makoto; Goda, Nobuhito.

Advances in Experimental Medicine and Biology. Vol. 662 2010. p. 77-82 (Advances in Experimental Medicine and Biology; Vol. 662).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Kondo, K, Sugioka, T, Tsukada, K, Aizawa, M, Takizawa, M, Shimizu, K, Morimoto, M, Suematsu, M & Goda, N 2010, Fenofibrate, a peroxisome proliferator-activated receptor a agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice. in Advances in Experimental Medicine and Biology. vol. 662, Advances in Experimental Medicine and Biology, vol. 662, pp. 77-82. https://doi.org/10.1007/978-1-4419-1241-1_10
Kondo K, Sugioka T, Tsukada K, Aizawa M, Takizawa M, Shimizu K et al. Fenofibrate, a peroxisome proliferator-activated receptor a agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice. In Advances in Experimental Medicine and Biology. Vol. 662. 2010. p. 77-82. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-1-4419-1241-1_10
Kondo, Kazunari ; Sugioka, Tadao ; Tsukada, Kosuke ; Aizawa, Michiyoshi ; Takizawa, Masayuki ; Shimizu, Kenji ; Morimoto, Masaya ; Suematsu, Makoto ; Goda, Nobuhito. / Fenofibrate, a peroxisome proliferator-activated receptor a agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice. Advances in Experimental Medicine and Biology. Vol. 662 2010. pp. 77-82 (Advances in Experimental Medicine and Biology).
@inproceedings{ced9e6fdc12f400fa76291c0b1197bac,
title = "Fenofibrate, a peroxisome proliferator-activated receptor a agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice",
abstract = "Nonalcoholic fatty liver disease (NAFLD) is a common disease of chronic liver diseases. Peroxisome proliferator-activated receptor a (PPARa) has been implicated to play important roles in the development of the disease. Beyond its effects on lipidmetabolisms, PPARa activation in the vascular system has emerged as an attractive therapeutic potential for NAFLD, although its actions in the microcirculatory system are not fully understood. In this study, we investigated the effects of fenofibrate, a PPARa synthetic agonist, on hepatic microcirculation in a high-fat diet (HFD)-induced fatty liver in mice. In vivo imaging analysis revealed the adverse effects of HFDon hepatic vasculature with narrowing of hepatic sinusoids and hepatic microcirculatory perfusion. Oxygen tension was significantly decreased in portal venules, while NADH autofluorescence in hepatocytes was greatly elevated. Fenofibrate treatment remarkably improved microvascular patency, tissue oxygenation and redox states in the affected liver. These results suggest beneficial roles of PPARa activated by fenofibrate on the regulation of both lipid metabolisms and microvascular environments of oxygen metabolism in HFD-induced fatty liver.",
author = "Kazunari Kondo and Tadao Sugioka and Kosuke Tsukada and Michiyoshi Aizawa and Masayuki Takizawa and Kenji Shimizu and Masaya Morimoto and Makoto Suematsu and Nobuhito Goda",
year = "2010",
doi = "10.1007/978-1-4419-1241-1_10",
language = "English",
isbn = "9781441912398",
volume = "662",
series = "Advances in Experimental Medicine and Biology",
pages = "77--82",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - GEN

T1 - Fenofibrate, a peroxisome proliferator-activated receptor a agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice

AU - Kondo, Kazunari

AU - Sugioka, Tadao

AU - Tsukada, Kosuke

AU - Aizawa, Michiyoshi

AU - Takizawa, Masayuki

AU - Shimizu, Kenji

AU - Morimoto, Masaya

AU - Suematsu, Makoto

AU - Goda, Nobuhito

PY - 2010

Y1 - 2010

N2 - Nonalcoholic fatty liver disease (NAFLD) is a common disease of chronic liver diseases. Peroxisome proliferator-activated receptor a (PPARa) has been implicated to play important roles in the development of the disease. Beyond its effects on lipidmetabolisms, PPARa activation in the vascular system has emerged as an attractive therapeutic potential for NAFLD, although its actions in the microcirculatory system are not fully understood. In this study, we investigated the effects of fenofibrate, a PPARa synthetic agonist, on hepatic microcirculation in a high-fat diet (HFD)-induced fatty liver in mice. In vivo imaging analysis revealed the adverse effects of HFDon hepatic vasculature with narrowing of hepatic sinusoids and hepatic microcirculatory perfusion. Oxygen tension was significantly decreased in portal venules, while NADH autofluorescence in hepatocytes was greatly elevated. Fenofibrate treatment remarkably improved microvascular patency, tissue oxygenation and redox states in the affected liver. These results suggest beneficial roles of PPARa activated by fenofibrate on the regulation of both lipid metabolisms and microvascular environments of oxygen metabolism in HFD-induced fatty liver.

AB - Nonalcoholic fatty liver disease (NAFLD) is a common disease of chronic liver diseases. Peroxisome proliferator-activated receptor a (PPARa) has been implicated to play important roles in the development of the disease. Beyond its effects on lipidmetabolisms, PPARa activation in the vascular system has emerged as an attractive therapeutic potential for NAFLD, although its actions in the microcirculatory system are not fully understood. In this study, we investigated the effects of fenofibrate, a PPARa synthetic agonist, on hepatic microcirculation in a high-fat diet (HFD)-induced fatty liver in mice. In vivo imaging analysis revealed the adverse effects of HFDon hepatic vasculature with narrowing of hepatic sinusoids and hepatic microcirculatory perfusion. Oxygen tension was significantly decreased in portal venules, while NADH autofluorescence in hepatocytes was greatly elevated. Fenofibrate treatment remarkably improved microvascular patency, tissue oxygenation and redox states in the affected liver. These results suggest beneficial roles of PPARa activated by fenofibrate on the regulation of both lipid metabolisms and microvascular environments of oxygen metabolism in HFD-induced fatty liver.

UR - http://www.scopus.com/inward/record.url?scp=77949889327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949889327&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-1241-1_10

DO - 10.1007/978-1-4419-1241-1_10

M3 - Conference contribution

SN - 9781441912398

VL - 662

T3 - Advances in Experimental Medicine and Biology

SP - 77

EP - 82

BT - Advances in Experimental Medicine and Biology

ER -